Page 24 - REVISED GP Fall 2021 - ready for posting
P. 24

Hermansky-Pudlak Syndrome:  A Case Study


                                 By Amir Soleimani, Marina A. Janzer, Young Kwang Kim, DMD, DMSc,
                                Angela R. Kamer, DMD, MS, PhD and Lucretia Depaola-Cefola, DDS, MS


        ABSTRACT                              LROs are organelles similar to lysosomes  does  not  recall  what  it  was. Additionally,
                                              in  that  they  share  specific  membrane  pro-  the  patient  reported  ocular  problems  such
        Introduction:  Hermansky-Pudlak  Syn-  teins  and have  an acidic  intralumenal  pH,  as light  sensitivity  and  oculocutaneous al-
        drome (HPS) is a rare genetic disorder that  but they derive from different processes and  binism  manifesting  as hypopigmentation
        is characterized by a variety of clinical man-  modifications  in  the  endosomal  system.   of the skin and eyes (Figure 1). The patient
                                                                                6
        ifestations including, but not limited to, oc-  Examples  of LROs include,
        ulocutaneous  albinism, visual  impairment,  but are not limited to, melano-
        inflammatory bowel diseases, and immune  somes, platelet alpha granules,
        dysfunction. Because  these patients  can  cytotoxic T-lymphocytes, and
        present with systemic complications  that  endothelial cell Weibel-Palade
        range in severity, specific modifications for  bodies.   The  inherited  gene
                                                   7
        each patient may be necessary in a dental  mutation  determines  which
        setting.                              function is impaired, leading
                                              to the various symptoms/signs
        Case presentation: A 35-year-old male pre-  observed; for example, muta-  Figure 1. Extraoral clinical presentation.
        sented to the New York University College   tions in melanosomes can lead to albinism  also reported  mild  to moderate  ulcerative
        of Dentistry for a routine clinical  exam.   while mutations  affecting  T-lymphocytes  colitis diagnosed in 2018, which is managed
        His medical history revealed a diagnosis of   can lead to immune deficiency.  The clinical  by oral mesalamine (1.2 grams BID).
                                                                      6
        HPS. After a thorough clinical examination,   presentation of the genetic mutation of an
        a diagnosis of generalized  mild periodon-  HPS patient will vary in severity depending  Dental History
        titis was made and a comprehensive treat-  on its location and role in the biosynthesis  The patient reported orthodontic treatment
        ment plan was formulated, consisting of full   of LROs.  The mechanism of inheritance of  as a child, from ages twelve to fifteen, which
                                                     7
        mouth scaling and root planing and regular   HPS is complex and varies greatly depend-  included the removal of all four permanent
        maintenance visits.                   ing on the specific gene inherited. Here, we  first premolars. He was eighteen years old
                                              present  a case  of a 35-year-old  male  with  when he had his last dental visit.
        Conclusion: HPS is a rare genetic disorder   mild HPS.
        that may require significant dental modifica-                              Extraoral Exam
        tions. Treatment modifications include pro-  CLINICAL REPORT               Extraorally,  the  patient  displayed  signs of
        tective eyewear, local hemostatic measures,   A 35-year-old male of Puerto Rican descent  albinism of his hair, skin, and eyes (Figure
        oral cancer screenings and consultation with   presented to New York University College  1). The patient did not display any asymme-
        physicians. Given the rarity of HPS, and the   of  Dentistry  for  a  routine  periodic  exam.  try or lymphadenopathy. Temporomandibu-
        consequent lack of published literature re-  The  patient  presented  with  a  chief  com-  lar joint exam findings and all other aspects
        garding dental  care for HPS patients,  this   plaint of, “I need a dental checkup,” and had  of the extraoral exam were within normal
        case report aims to contribute to the litera-  no other outstanding concerns.   limits.
        ture available on the dental presentation and
        management of HPS patients.           Medical History                      Intraoral Exam
                                              Medical history revealed that the patient was  Intraorally, the  patient  had multiple  amal-
        KEY WORDS: Hermansky-Pudlak  Syn-     diagnosed with HPS when he was approxi-  gam restorations in the maxillary and man-
        drome, dental treatment modification  mately five to ten years old. The inherited  dibular molars (Figures 2-4).  The buccal
                                              variant of HPS was unknown to the patient  mucosa exhibited bilateral linea alba. There
        INTRODUCTION                          and no genetic analysis has been performed.
                           1
        First reported in 1959,  Hermansky-Pudlak   The patient confirmed that his siblings sim-
        Syndrome is a rare autosomal recessive dis-  ilarly display mild forms of HPS.
        ease affecting protein and organelle  func-
            2
        tion.  It is believed to affect 1 in 500,000 to   In general, the patient reported mild symp-
        1 in 1,000,000 people in the general popula-  toms  of HPS. However, he  described  re-
        tion, but more frequently among the Puerto   quiring  hemostatic  premedication  prior  to
        Rican population, where prevalence is esti-  extractions  required  for orthodontics  as a
                                 3
        mated to be around 1 in 1,800.        teenager. He  reported  that  an  intravenous   Figure 2. Pre-treatment intraoral
                                              premedication was administered although he   presentation.
        HPS patients may present with a wide vari-
        ety of symptoms, including oculocutaneous
        albinism, prolonged bleeding, pulmonary fi-
        brosis, granulomatous colitis, and immuno-
        deficiency;  the symptoms and their severi-
                  4
        ty vary depending on the inherited mutation.   Figure 3. Pre-treatment intraoral series of the maxilla.
        To date, ten different gene mutations have
        been implicated in HPS, all of which encode
                                           5
        for lysosome-related  organelles  (LROs).

        www.nysagd.org l Fall 2021 l GP 24       Figure 4. Pre-treatment intraoral series of the mandible.
   19   20   21   22   23   24   25   26   27   28   29